"十五五"期间，北京市疾控系统将优化各类传染病监测预警体系，加强蚊媒、蜱媒等病媒生物监测与控 制。 在近日开幕的北京市两会上，新京报记者专访北京市人大代表、北京市疾控中心主任王全意，介绍疾控 系统未来五年的重点工作。 今年，流感的提前到来引发公众讨论。哪些因素影响流感流行？北京市情况如何？作为传染病防控专 家，王全意也对此进行了专业解答。 北京市人大代表、北京市疾控中心主任王全意。新京报记者 王贵彬 摄 "十五五"期间，加强媒介传染病防控 新京报：今年是"十五五"的开局之年，北京市卫生领域重点规划工作中提到了建设首都公卫中心、推进 过敏原和病媒生物防控协同治理等内容，市疾控有哪些重点工作将推进？ 王全意：锚定"十五五"新征程，我们将擘画首都疾控高质量发展新蓝图。 我们会继续织密传染病防控网络，包括优化呼吸道、肠道、虫媒等各类传染病监测预警体系，加强蚊 媒、蜱媒等病媒生物监测与控制，防范输入性传染病本地传播。新增发热伴出血等重点症候群监测，提 升早期识别、快速响应、应急处置能力；持续做好艾滋病、结核病、丙肝等重点传染病防控，保持低流 行水平等。 "十五五"期间，我们要发挥北京重大呼吸道传染病研究中心、新发传染病 ...

市疾控中心副主任吴寰宇同步解读三大重点项目成效。他说，在传染病防控领域，上海构建"监测—预 警—处置"闭环，制定发热及肠道门诊地方标准，实现数据全采集，首创"社区+医院"双轨监测模式，建 立1.5万人社区队列。AI预警模型可提前2周预判疫情及医疗负荷，评估精度达街镇级，为冬春季流感防 控提供支撑；气象预警技术入选世卫案例，后续将发布感冒指数。建成一流应急作业中心，5G技术赋 能流调，实现现场与指挥中心实时联动。 在生物安全领域，实现病原检测溯源突破，云端研判系统构建生物样本数字信息库，可48小时定位未知 病原、24小时完成30例样本溯源，同步搭建"微生物资源共享超市"。形成"申"字形实验室网络，以市疾 控为核心、6家区疾控为枢纽，统一标准实现检测同质化。构建"人—动物—环境"监测网，耐药基因监 测覆盖排水系统，气传微生物监测延伸至重点场所，类器官平台助力生物医药创新。 本轮重点推进四大工程：应急能力上，构建智能传染病监测预警与响应体系，完善平急结合救治体系， 布局传染病临床诊治中心（IDC）体系；服务能力上，优化市区疾控实验室布局，打造传染病防治监管 平台与健康促进融媒体中心；协同能力上，构建儿童青少年常见病 ...

中新网上海1月17日电 (记者 陈静)在16日举行的上海市加强公共卫生体系建设三年行动计划(2023—2025 年)(上海第六轮公卫三年行动计划)媒体通气会上，上海市卫生健康委副主任，上海市疾控局党组书记、 局长张浩表示，在圆满收官的上海第六轮公卫三年行动计划中，上海超大城市风险防控能力系统性增 强。 据悉，上海的"智慧卫监"接入城市运行"一网统管"，扩大"无感监测"对象清单，强化风险管理的同时做 到"无事不扰"，持续优化营商环境。 在监测网络方面，上海优化354家发热门诊、227家肠道门诊监测效能，新增7家儿童综合监测点，拓展8 个媒体信息监测源和3种监测病种，部署病媒生物一体化设备，实现蚊虫实时动态监测，同步升级523家 医疗机构传染病直报智能插件，填报时间缩短50%，形成全场景、全时段的风险感知网络。 在智能预警方面，上海打通数据壁垒，创新气象—传染病风险预报技术，相关成果入选世界卫生组织 《气候与健康问题特别报告》城市示范案例。在应急响应方面，上海首次建立了大型应急处置场所建筑 模块化布局标准以及一套运行管理规范；上海市疾控中心已建成集信息实时汇聚、风险智能研判于一体 的应急作业中心(EOC)。在检验 ...

Core Insights - The article emphasizes the increased risk of infectious diseases during January due to winter conditions and heightened human activity around the New Year, particularly respiratory and gastrointestinal infections, as well as non-occupational carbon monoxide poisoning [1] Group 1: Influenza - Influenza is an acute respiratory infectious disease caused by the influenza virus, characterized by symptoms such as chills, high fever, headache, and fatigue, typically lasting 3-4 days [2] - Although influenza cases in the province are currently on a downward trend, they remain within the seasonal epidemic period, with a heightened risk in densely populated areas like schools and nursing homes [2] Group 2: Norovirus Infection - Norovirus is highly contagious and is a leading cause of acute gastroenteritis, transmitted through contaminated food, water, or surfaces, with common sources including shellfish and raw fruits and vegetables [4] - The winter season marks a peak period for norovirus infections, particularly in crowded settings such as schools and childcare facilities, necessitating public vigilance and personal protective measures [4] Group 3: Non-occupational Carbon Monoxide Poisoning - Non-occupational carbon monoxide poisoning exhibits a clear seasonal pattern, peaking from November to March, coinciding with heating demands during colder months [7] - The article warns of an expected increase in carbon monoxide poisoning incidents in January due to rising heating needs, with symptoms ranging from mild to severe, potentially leading to high mortality rates in severe cases [7]

Group 1 - The discussion focused on improving vaccine effectiveness and safety, highlighting the limitations of current mucosal immune mechanisms and basic immunology research in developing efficient and long-lasting vaccines [1][3] - The event, part of the "Cape of Good Hope Science Salon," gathered over 130 participants, including experts, entrepreneurs, and investment leaders, to explore the latest research and investment logic in pathogen research and infectious disease prevention [1][3] Group 2 - Gao Fu, a prominent immunologist and academician, emphasized that the viruses likely to cause future large-scale outbreaks are influenza and coronaviruses due to their respiratory nature and propensity for mutation [3] - He discussed various vaccine development strategies adopted in China post-COVID-19, including inactivated, live attenuated, protein subunit, viral vector, mRNA, multivalent, and virus-like particle vaccines, with a focus on protein subunit vaccines [4] - Recent breakthroughs in vaccine research include the development of the world's first recombinant subunit vaccine for COVID-19, with advancements in design strategies to enhance broad-spectrum efficacy [4]

Group 1 - The provincial health office has issued a notice to strengthen urban and rural sanitation efforts and enhance vector control to aid in the prevention of key infectious diseases, with activities running until March 2026 [1] - The activities will focus on environmental sanitation, vector control, patriotic health campaigns during the New Year, and health education [1] - Localities are required to organize major sanitation activities around key holidays, with specific deadlines for community clean-up events set for December 2025 and February 2026 [1] Group 2 - During the peak season for respiratory and intestinal infectious diseases, localities are urged to focus on flu and norovirus prevention, utilizing media to disseminate knowledge on disease control [2] - Community awareness campaigns will be enhanced through updated public information on personal protective measures, fostering a supportive environment for disease prevention [2] - The provincial health office, in collaboration with disease control experts, has produced educational videos on vector control, which are currently available on online platforms [2]

Core Viewpoint - The rapid identification of pathogens has become a critical component of public health prevention and clinical diagnosis, prompting the company to initiate a collaborative project aimed at developing a specialized pathogen detection system [1] Group 1: Project Overview - The company’s subsidiary, Tianjin BGI Medical Testing Co., Ltd., plans to jointly apply for a national science and technology major project focused on the development of a convenient long-read sequencing system for pathogen detection [1] - The total funding for the joint application project is 120 million yuan, with 20 million yuan requested from the national budget and 100 million yuan to be self-funded by the participating institutions [1] - Among the self-funded amount, Tianjin BGI Medical Testing Co., Ltd. will contribute 50 million yuan [1] Group 2: Project Participation - Tianjin BGI Medical Testing Co., Ltd. will participate in three specific topics within the project, focusing on the development of pathogen single-molecule detection kits, supporting algorithms, databases, and research on automation applications [1]

Group 1 - The core point of the article is that Chengda Biological has signed a strategic cooperation agreement with the Institute of Microbiology, Chinese Academy of Sciences, focusing on emerging infectious diseases and vector-borne disease prevention [2] - The collaboration aims to jointly apply for national and provincial-level scientific research projects to enhance efforts in infectious disease prevention and control [2] - This partnership signifies a strategic move to leverage academic research capabilities in addressing public health challenges related to infectious diseases [2]

Core Insights - Chengda Biologics (688739.SH) has signed a strategic cooperation agreement with the Institute of Microbiology, Chinese Academy of Sciences, focusing on emerging infectious diseases [1] - The collaboration aims to jointly apply for national and provincial-level research projects, enhancing efforts in infectious disease prevention and control [1] - This strategic partnership integrates top resources in pathogen research from the Institute of Microbiology with the existing vaccine development platform of the company, accelerating the development of vaccines and biopharmaceuticals for emerging infectious diseases [1]

Core Viewpoint - Chengda Bio (688739) has signed a strategic cooperation agreement with the Institute of Microbiology, Chinese Academy of Sciences, focusing on emerging infectious diseases and vector-borne disease prevention [1] Group 1 - The cooperation aims to jointly apply for national and provincial-level research projects to enhance efforts in infectious disease prevention and control [1] - The agreement is categorized as an intention-based collaboration and does not have a direct impact on the company's performance for 2025 and beyond [1]